Long-Term Outcome of Aromatase Inhibitor Therapy With Letrozole in Patients With Advanced Low-Grade Endometrial Stromal Sarcoma.

@article{Yamaguchi2015LongTermOO,
  title={Long-Term Outcome of Aromatase Inhibitor Therapy With Letrozole in Patients With Advanced Low-Grade Endometrial Stromal Sarcoma.},
  author={M Yamaguchi and Chimeddulam Erdenebaatar and Fumitaka Saito and Takeshi Motohara and Yo Miyahara and Hironori Tashiro and Hidetaka Katabuchi},
  journal={International journal of gynecological cancer : official journal of the International Gynecological Cancer Society},
  year={2015},
  volume={25 9},
  pages={1645-51}
}
BACKGROUND There has been no consensus on the indications for the treatment of advanced low-grade endometrial stromal sarcoma (LGESS), and the possible effects of hormonal treatment including progestins and aromatase inhibitors have been reported. The aim of this study was to investigate the efficacy of aromatase inhibitor therapy with letrozole for… CONTINUE READING